Role of Circulating Tumor Cells/DNA & Liquid Biopsy in Melanoma - David Polsky
David Polsky MD,PhD Professor of Cutaneous Oncology at NYU discusses the role of Circulating Tumor DNA and Liquid Biopsy in Melanoma care in the Metastatic and Adjuvant settings
▶︎
Circulating Tumor Cell Analysis: Delivering on the Promise of Liquid Biopsy
▶︎
Archive: Circulating Tumor Cells Circa 2020
▶︎
Ask the Expert: Key Takeaways from ASCO – Advances in Cutaneous & Rare Melanoma Subtypes
▶︎
22 Principles of Biomarker Testing: Part 2 The Liquid Biopsy
▶︎
Adjuvant therapy for Melanoma - Amaria
▶︎
The French Do Not Care About Work
▶︎
Squamous Cell Carcinoma & Actinic Keratosis 101...Dermpath Basics & Beyond
▶︎
Emerging Role of Circulating Tumor DNA in the Management of Thoracic Malignancies (Sept. 26, 2024)
▶︎
Metastatic Melanoma - Doublet vs Triplet therapy
▶︎
ColonCancerCheck Program Changes, Risk Based Screening and Surveillance Recommendations
▶︎
Detection of mutations from liquid biopsies - applications in cancer diagnostics
▶︎
It's NOT Memory - 5 Early Dementia Signs Everyone Misses
▶︎
Dermatologist Explains: How To Spot Skin Cancer Early!
▶︎
Use These 5 Food Hacks To Heal The Body & STARVE CANCER I Dr. William Li
▶︎
What’s New in Brain and Spine Metastases Treatment May 13th 2026
▶︎
WCR Updates Webinar Series - Liquid Biopsy-Based Biomarkers for Cancer Detection and Monitoring
▶︎
Subtypes of Melanoma and Unique Patient Populations
▶︎
Recurrent mutations in melanoma detected by genome sequencing
▶︎
Medical Historian Answers History of Medicine Questions | Tech Support | WIRED
▶︎